See Obesity, Think Liver
Understanding obesity and liver health
Obesity and liver disease are no longer separate challenges—they represent a growing, interconnected health crisis. Metabolic dysfunction-associated steatohepatitis (MASH), formerly known as NASH, is closely linked to obesity and metabolic syndrome, yet often remains underdiagnosed until advanced stages. Together, we can improve patient outcomes by addressing these intertwined epidemics through informed, holistic care.
This platform is designed to equip healthcare professionals with evidence-based insights, practical tools, and educational resources to better:
Your understanding of the interconnected nature of obesity and MASH, recognising shared metabolic and inflammatory mechanisms.
The need for timely screening, earlier diagnosis and earlier referrals to target obesity and prevent or slow MASH disease progression.
Explore obesity and liver
Discover obesity as a complex, chronic, and relapsing metabolic disease with a significant impact on health and quality of life.
Explore the liver's role in cardiometabolic health and the importance of early MASLD/MASH diagnosis and treatment.
Obesity and MASH are deeply interconnected conditions that drive cascading health risks far beyond the liver or the scale.
Your go-to resource for evidence-based tools and practical support to advance clinical practice in obesity and liver health.
Share your feedback to help shape upcoming educational content!
SC-GB-03740 | May 2026
Phone UK: 01344 742579 & Ireland: 01 295 9620
Email: Medinfo.bra@boehringer-ingelheim.com
Business hours: 9am-5pm Mon-Thurs, 9am-4pm Fri
Phone UK: 0800 328 1627 & Ireland: 01 291 3960